Key facts
- This page summarizes Peter W. Sonsini's Form 4 filing for GENOCEA BIOSCIENCES, INC..
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 26 May 2022, 18:31.
Peter W. Sonsini - 24 May 2022 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 24 May 2022
- Net transaction value
- -$750,662
- SEC form
- 4
- Accepted by SEC
- 26 May 2022, 18:31:41 UTC
- Prior SEC filing
- 04 May 2022
- Next SEC filing
- 19 Oct 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Louis Citron, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Peter W. Sonsini filed Form 4 for GENOCEA BIOSCIENCES, INC. on 26 May 2022.
Change
- Previous filing in this sequence was filed on 04 May 2022.
- Current net transaction value: -$750,662.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GNCA
transaction
Common Stock
Sale
- Transaction value
- $387,943
- Shares
- -5,931,843
- Change %
- -57%
- Price
- $0.0654*
- Shares after
- 4,445,093
- Date
- 24 May 2022
- Ownership
- See Note 2
- Footnotes
- F1, F2
GNCA
transaction
Common Stock
Sale
- Transaction value
- $362,720
- Shares
- -4,445,093
- Change %
- -100%
- Price
- $0.0816*
- Shares after
- 0
- Date
- 25 May 2022
- Ownership
- See Note 2
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Peter W. Sonsini is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.060 to $0.0746, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
Footnote F2
The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.0675 to $0.0980, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.